Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

about

Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art.Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.

P2860

Q38690844-D65B2C9F-04FF-4ED1-AA62-4BCC6BE848EB Q39160729-1524F22B-05AD-4A22-ACCD-4F37CC06EF5F Q55163735-926E2E79-516D-49A4-8F86-50EC637C8654

P2860

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

Item

http://www.wikidata.org/entity/Q39425964

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

@en

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

@nl

type

Item

label

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

@en

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

@nl

prefLabel

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

@en

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

@nl

P1476

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

@en

P2093

Chi Chiu Mok

http://www.w3.org/2001/XMLSchema#string

P2860

Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury.

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.

Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature.

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Calcineurin inhibitor nephrotoxicity.

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.

Prognostic factors in lupus nephritis.

P304

1561-1566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFW289

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27591327

http://www.w3.org/2001/XMLSchema#string

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

about

P2860

P2860

Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698